Beckman Coulter Vidiera™ NsD & CEQ™ Series Detection System Assays
November 2004:
Beckman Coulter and InVivoScribe Technologies have signed a long-term collaborative development agreement. This agreement was formally announced during Corporate Symposia at the Association for Molecular Pathology meeting. Under this agreement InVivoScribe Technologies will provide gene rearrangement assays formatted and validated for Beckman Coulter’s new Vidiera™ NsD Instrument as well as the existing CEQ™ Series platforms. We look forward to working closely with the dedicated team of professionals from Beckman Coulter. These Beckman Coulter formatted B & T Cell Clonality Tests are now available.
